In patients with diabetes, semaglutide use was associated with an increased risk for nonarteritic anterior ischemic optic neuropathy, according to a study published in JAMA Ophthalmology.
As Healio previously reported, this potential link was observed in a study by Jimena Tatiana Hathaway, MD, MPH, and colleagues. The findings were limited, however, by a small sample size of 710 patients from a single institution, Alan Y. Hsu, MD, of the department of ophthalmology at China Medical University Hospital in Taiwan, and colleagues wrote in the current study.
“Therefore, our study used the